Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Crabbe

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
FEBS Letters|January 8, 1996
The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its functionU Gohlke, F X Gomis-Rüth, T Crabbe, et al.
Annals of the New York Academy of Sciences|September 6, 1994
Regulation of matrix metalloproteinase activityG Murphy, F Willenbrock, T Crabbe, et al.
Biochemistry|September 15, 1992
Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinasesT Crabbe, F Willenbrock, D Eaton, et al.
Oncogene|August 9, 2007
Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTORV Veverka, T Crabbe, I Bird, et al.
Cellular Signalling|January 16, 1998
Molecular cloning and expression of a human phosphodiesterase 4CR J Owens, S Lumb, K Rees-Milton, et al.
Biochemistry|May 31, 1994
Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1T Crabbe, S Zucker, M I Cockett, et al.
The Journal of Biological Chemistry|December 22, 1995
Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranesS J Atkinson, T Crabbe, S Cowell, et al.
Biochemical Society Symposium|March 26, 1998
Matrix metalloproteinases and metastatic cancerM I Cockett, G Murphy, M L Birch, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
4-Pyridin-5-yl-2-(3,4,5-trimethoxyphenylamino)pyrimidines: potent and selective inhibitors of ZAP 70D Moffat, P Davis, M Hutchings, et al.
Journal of Pharmaceutical Sciences|April 1, 1995
An in vivo model for screening peptidomimetic inhibitors of gelatinase AS K Chander, P Antoniw, N R Beeley, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
FEBS Letters|January 8, 1996
The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its functionU Gohlke, F X Gomis-Rüth, T Crabbe, et al.
Annals of the New York Academy of Sciences|September 6, 1994
Regulation of matrix metalloproteinase activityG Murphy, F Willenbrock, T Crabbe, et al.
Biochemistry|September 15, 1992
Biochemical characterization of matrilysin. Activation conforms to the stepwise mechanisms proposed for other matrix metalloproteinasesT Crabbe, F Willenbrock, D Eaton, et al.
Oncogene|August 9, 2007
Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTORV Veverka, T Crabbe, I Bird, et al.
Cellular Signalling|January 16, 1998
Molecular cloning and expression of a human phosphodiesterase 4CR J Owens, S Lumb, K Rees-Milton, et al.
Biochemistry|May 31, 1994
Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1T Crabbe, S Zucker, M I Cockett, et al.
The Journal of Biological Chemistry|December 22, 1995
Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranesS J Atkinson, T Crabbe, S Cowell, et al.
Biochemical Society Symposium|March 26, 1998
Matrix metalloproteinases and metastatic cancerM I Cockett, G Murphy, M L Birch, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
4-Pyridin-5-yl-2-(3,4,5-trimethoxyphenylamino)pyrimidines: potent and selective inhibitors of ZAP 70D Moffat, P Davis, M Hutchings, et al.
Journal of Pharmaceutical Sciences|April 1, 1995
An in vivo model for screening peptidomimetic inhibitors of gelatinase AS K Chander, P Antoniw, N R Beeley, et al.
Pageof 3